Use patterns of systemic immunomodulators in the United States before and after dupilumab approval in adults with atopic dermatitis is a research paper published in Pharmacoepidemiology and Drug Safety (2022). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIAMS NIH HHS
Grant: R01 AR080194
National Institutes of Health
FWCI
0.62
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals